BRIOTA Technologies: Innovation enhancing lung health!!

Timely diagnosis and treatment of respiratory diseases remain to be a major concern for the healthcare sector. For decades, lung diseases like Chronic Obstructive Pulmonary Disease (COPD) have been one of the most common causes of death in the world. The healthcare system is continuously embracing contemporary measures and innovations to prevent, control and manage both infectious and non-communicable lung diseases. New-fangled digital technologies have transformed the healthcare system and empowered physicians to hit on innovative methods to enhance patient outcomes and deliver quality care to patients.

A Pune-based startup, Briota Technologies, has come forward to unleash potential technologies to develop effective solutions and bridge the gaps in healthcare services, giving prominence to enhancing the screening, diagnostic, care, and management of chronic respiratory conditions.

Briota was set up by Gajanan Sakhare and Shardul Joshi, both of whom were passionate about using AI to help improve Health Equity. The startup is focused on devising AI-first technology solutions in an affordable and accessible manner. The team of Briota Technologies has developed cost-effective innovative products and services to simplify the screening, diagnosis, and treatment process for Asthma, COPD, Long Covid, and Post TB Lung complications. They aim to make quality care affordable and accessible for all through their flagship offering SAVE (Screening, diagnosis, management Assisted Virtually and Early). SAVE project has helped more than 40 thousand patients manage their lung health during the pandemic.

Briota Technologies is among the 12 startups that were part of the sixth edition of Qualcomm Design in India Challenge (QDIC) – an initiative to encourage design houses and product companies to invent useful and innovative hardware product designs incorporating Qualcomm SoC platforms and technologies. Through QDIC, Briota had the opportunity to convert its design submissions into workable prototypes under the mentorship of industry experts, utilizing the Qualcomm® Innovation Lab infrastructure.

“Qualcomm cohort was like a fast track MIT course in hardware design thinking for us!! We are glad that we could be part of such cohort covering practical issues and challenges for a hardware startup. We got lot of insights from Qualcomm team and also got lot of shared learning from other participants. We could get access to the right people and right resources in one place. Specifically, I would like to highlight Qualcomm team’s support around patent filing process,” says, Gajanan Sakhare, Founder, Briota Technologies.

This MedTech firm has crafted solutions like:

• SiA™ (Systematic Intervention Agent): AI First platform which is fully implemented for Asthma, COPD and Long Covid and can be extended to any other chronic condition to be managed at home. This platform is available in SaaS (Software As A Solution) and Custom Development model for other startups and established companies.
• SpiroPRO™: The ease-to-use device is designed to streamline screening, diagnosis, monitor treatment, enable real-time data of the lung health and in a few seconds connect and share reports with the physicians. These tests are CDSCO approved and are accurate to laboratory standards. It has helped doctors take better medical decisions and expedite medication.
• NEHA™: This light and handy smart app supports patients, doctors and caregivers at every step. Its works as an all-inclusive store that allows the user to book an appointment to consult a physician, maintain the medicine time-table and keep a tab on the lung health.
• Inhaler PRO^TM : A one-off smart inhaler, Inhaler Pro^TM works in sync with app NEHA to document the health statistics, frequency, and medication guideline of the patient. These particulars help in monitoring Asthma patients, and help make smart choices about the medicines that promotes health. It detects temperature, puff counts and SpO2.
• BreathPRO^TM: This mechanical exerciser is a unique innovation that helps enhance lung capacity by reducing mucous in airway. It helps in improving respiratory ailments such as Asthma, COPD and others.

These technology solutions have played a notable role in addressing the unmet challenges in this pandemic time, focussing on the early detection of asthma and COPD in children and elderly patients. The products are ISO 9001:2015 & ISO 13485:2016 certified and are approved by Central Drugs Standard Control Organisation (CDSCO).

One of its top-notch initiatives powered by their AI-powered Platform SiA™ is a 12 months customized lung care program which takes a holistic approach of managing lung health at home. It includes simple mobile application for improving adherence and support from coaches and medical staff through remote video calls.

“Besides innovating devices that help reduce the burden of chronic respiratory diseases, we wanted to build a platform that will proffer patients personalized programs to Asthma and Covid19 patients. We have got the best-in-class coaches who are qualified Respiratory Therapists, Yoga Experts, Emotional Wellness Experts, Physiotherapists, and Nutritionists. They closely work with the patient to understand their requirement and curate the suitable lung program for them,” commented Shardul Joshi, Co-Founder, Founder of Briota Technologies.

Briota Technologies added many feathers to its cap! Excellence in Innovation Healthcare Start-up of the Year 2021 Award was conferred to the startup by the Organisation of Pharmaceutical Producers of India (OPPI). They won this award for improving health equity through their affordable SpiroPRO™ device and SAVE programs. The start-up received a year-long mentorship from Bayer Pharmaceuticals. It has also bagged “SKOCH Order of Merit Semi-Finals Award 2020” for Project SAVE at the 67th SKOCH Summit on the state of governance. Briota and it’s founder Gajanan is now invited Denmark Government under their Startup promotion program to setup Briota operations in Denmark.  Now Briota is working from both locations – Pune, India and Copenhagen, Denmark.

A bootstrapped firm, Briota has raised initial research capital through soft money and is now initiated fundraising activities. The team plans to go for MedTech focused IPO in Denmark in next two years. The company has signed up collaboration agreements with two leading pharmaceutical companies and is working closely with multiple hospitals in India and Europe. Apart from their proprietary hardware system, they are also partnering with various other hardware providers to expand coverage of our SaaS platform. With the clinical validation in Denmark and CE marking to be completed by December 2023, Briota is working on a plan to expand in Europe, Japan and the USA.

To date, the startup has crowned other significant projects such as the “VIEW “Pilot Study on COVID Diagnosed Mild & Asymptomatic Patients in Dec 2020, which was done in collaboration with Symbiosis Center of Health Care has completed  In 2020, Briota technologies completed another important project called “SURAKSHA 2020” in partnership with Xynteo New Growth Lab Foundation for Corporates.

For any further information\query you can write to us at Co-innovate@nasscom.in.